Intra-Cellular Therapies, Inc
3 drugs in NADAC|0 Generic,3 Brand
Intra-Cellular Therapies, Inc lists 3 NDCs in the CMS NADAC file (0 generic, 3 brand), at an average NADAC of $57.27 per unit, with a week-over-week move of -0.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
3
0G / 3B
Avg Price / Unit
$57.2738
$57.26 – $57.29
Avg 7d Change
-0.05%
Across 1 drugs with changes
7d Activity
of 3 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does Intra-Cellular Therapies, Inc make?
Intra-Cellular Therapies, Inc lists 3 NDCs in the CMS NADAC file — 0 generic and 3 brand products.
What is the average price of Intra-Cellular Therapies, Inc drugs?
The average NADAC across Intra-Cellular Therapies, Inc's portfolio is $57.2738 per unit, ranging from $57.2626 to $57.2923.
What types of drugs does Intra-Cellular Therapies, Inc make?
Intra-Cellular Therapies, Inc makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Atypical Antipsychotic (3).
Has Intra-Cellular Therapies, Inc had any drug recalls?
No FDA enforcement recalls are matched to Intra-Cellular Therapies, Inc in the openFDA feed.
How has Intra-Cellular Therapies, Inc's pricing changed recently?
Over the past 7 days, 0 Intra-Cellular Therapies, Inc products rose and 1 fell, with a portfolio-wide average change of -0.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CAPLYTA 10.5 MG CAPSULE lumateperone | $57.2923 per EA | 0.00% |
CAPLYTA 42 MG CAPSULE lumateperone | $57.2666 per EA | 0.00% |
CAPLYTA 21 MG CAPSULE lumateperone | $57.2626 per EA | -0.05% |